Skip to main content

Table 1 Baseline characteristics of the four groups

From: Use of marginal organs in kidney transplantation for marginal recipients: too close to the margins of safety?

  Group 1:
Donor and
recipient
non-marginal
Group 2:
Donor non-
marginal,
recipient
marginal
Group 3:
Donor
marginal,
recipient
non- marginal
Group 4:
Donor and
recipient
marginal
P-value
No. of patients 138 41 69 84 -
Females (%) 55 (39.9%) 20 (48.8%) 30 (43.5%) 28 (33.3%) 0.359
Recipient age (years) 42.7 ± 10.4 61.8 ± 5.0 42.7 ± 10.1 64.5 ± 5.1 < 0.001
Recipient body mass index (kg/m2) 24.7 ± 4.6 25.5 ± 4.0 23.9 ± 3.5 25.4 ± 3.8 0.102
Recipient comorbidity      
   Arterial hypertension 14 (10%) 5 (12%) 9 (13%) 4 (5%) 0.325
   Arteriosclerotic disease 15 (11%) 19 (46%) 7 (10%) 26 (31%) < 0.001
   Heart insufficiency 10 (7%) 4 (10%) 2 (3%) 8 (10%) 0.387
   Diabetes mellitus 11 (8%) 14 (34%) 3 (4%) 15 (18%) < 0.001
   Thyroid disease 9 (7%) 2 (5%) 7 (11%) 9 (11%) 0.528
   Secondary hyperparathyreoidism 91 (66%) 24 (60%) 44 (66%) 54 (68%) 0.907
   Tertiary hyperparathyreoidism 8 (6%) 3 (8%) 4 (6%) 2 (3%) 0.907
   Hypercholesterolemia 18 (13%) 8 (20%) 14 (20%) 33 (40%) < 0.001
   Chronic obstructive lung disease 8 (6%) 2 (5%) 2 (3%) 5 (6%) 0.808
Duration of dialysis (months) 72 (42) 67 (36) 86 (55) 63 (35) 0.007
First transplantation 101 (73%) 34 (83%) 50 (73%) 66 (79%) 0.802
HLA-DR mismatches (0/1/2) 46 (33%) 14 (34%) 26 (38%) 18 (21%)  
  60 (43%) 15 (37%) 28 (41%) 32 (38%) 0.083
  32 (23%) 12 (29%) 15 (22%) 34 (41%)  
Same gender transplantation 60 (44%) 21 (51%) 35 (53%) 47 (56%) 0.571